Loading…
Loading…
The iShares U.S. Healthcare ETF is designed to mirror the investment performance of a benchmark index that consists of stocks from American companies within the healthcare industry.
Is IYH's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Vanguard Health Care ETF provides significantly broader exposure with 411 holdings compared to 100 for iShares U.S. Healthcare ETF. The Vanguard fund maintains a lower expense ratio of 0.09%, while the iShares fund charges 0.37%.
Shares of iShares U.S. Healthcare ETF (NYSEARCA:IYH - Get Free Report) saw unusually-high trading volume on Friday. Approximately 614,797 shares changed hands during mid-day trading, a decline of 22% from the previous session's volume of 789,866 shares. The stock last traded at $74.7480 and had previously closed at $74.49. iShares U.S. Healthcare ETF Stock Down
First Citizens Bank and Trust Co. purchased a new stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 9,175 shares of the company's stock, valued at approximately $657,000. A number of other institutional
The iShares U.S. Healthcare ETF offers a lower expense ratio and a higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides concentrated exposure to over 200 biotech companies, while the iShares U.S. Healthcare ETF holds 100 diverse healthcare positions.
iShares Global Healthcare ETF provides broad exposure to international medical companies with a higher dividend yield than its domestic counterpart. iShares U.S. Healthcare ETF concentrates on American companies and has produced higher total returns over the past year and five-year periods.